USMA Identifies “Multiple Irregularities” by the FDA When Considering New Medications
As many of our members are aware, the United States Medical Association (USMA) submitted an amicus brief in the Mifepristone case filed against the Food and Drug Administration by the Alliance for Hippocratic Medicine. The case arose from a dispute…